Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma
about
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor modelsCNS Anticancer Drug Discovery and Development Conference White Paper.Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer.Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.Array of translational systems pharmacodynamic models of anti-cancer drugs.Tyrosine kinase inhibitors show different anti-brain metastases efficacy in NSCLC: A direct comparative analysis of icotinib, gefitinib, and erlotinib in a nude mouse model.
P2860
Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Intratumoral modeling of gefit ...... ic mouse model of glioblastoma
@en
Intratumoral modeling of gefit ...... c mouse model of glioblastoma.
@nl
type
label
Intratumoral modeling of gefit ...... ic mouse model of glioblastoma
@en
Intratumoral modeling of gefit ...... c mouse model of glioblastoma.
@nl
prefLabel
Intratumoral modeling of gefit ...... ic mouse model of glioblastoma
@en
Intratumoral modeling of gefit ...... c mouse model of glioblastoma.
@nl
P2093
P2860
P1433
P1476
Intratumoral modeling of gefit ...... ic mouse model of glioblastoma
@en
P2093
James M Gallo
Jyoti Sharma
P2860
P304
P356
10.1158/0008-5472.CAN-13-0690
P407
P577
2013-06-24T00:00:00Z